Nuvelo (Nasdaq: NUVO) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nuvelo (Nasdaq: NUVO)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: AnnieO who wrote (127)	2/21/2000 3:55:00 PM
From: John Starks	Read Replies (1) of 286

i am a long time holder and have been obviously happy with the stock. i haven't contributed to the thread for awhile. the litigation has been a concern of mine as well but ceo lou gruber is a former patent attorney and i am pretty confident in their position, ie, their sbh technology appears to me (albeit i am a mol bio researcher, not a patent attorney!) to be distinct from arrays generally which is the affx holding. i am more concerned with the company's apparent goal of positioning itself as a pharma firm rather than a genomics company...three pre-clinical products will not sustain 1/10th its current value. wall street insists on lumping it with genomics stocks which accounts for the crazy run up obviously. lets hope the street continues to ignore the company's misguided attempt to redirect investor perception. i welcome any thoughts on the matter. John

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next